Gadolinium Toxicity

Home » News » Lawsuit filed against gadolinium-based contrast agent manufacturer

Lawsuit filed against gadolinium-based contrast agent manufacturer

Breaking News

breakingnews

July 21, 2017 – European Medical Authority takes action on Linear Contrast Agents.  Read all about it.

March 10, 2017 – European group recommends to stop using 4 linear GBCAs Read all about it.

February 27, 2017 – New Study Reports Gadolinium Retention in 70 Cases with Normal Kidney Function. Read all about it.

Enter your email address to follow this blog and receive notifications of new posts by email.

Viewpoint Categories

Monthly Archives

On November 1, 2017, Chuck and Gena Norris filed a lawsuit against 11 companies involved in the manufacture and distribution of two gadolinium-based contrast agents (GBCAs).  The $10 million lawsuit was filed in San Francisco County Superior Court by Todd Walburg of Cutter Law.  While it is not the only lawsuit that has been filed recently against MRI contrast agent manufacturers, it is the first high-profile case.

Chuck and Gena Norris have brought much needed media attention to the issue of gadolinium retention from contrast-enhanced MRIs.  We hope the media will continue to investigate the problems involving gadolinium-based contrast agents.  We believe that Gena’s case is just the tip of the iceberg when it comes to gadolinium toxicity from GBCAs.

We anticipate that there will be ongoing media coverage of this story and that readers will get the most up-to-date information by doing a search of the Internet.


Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: